Comparison of the aneugenic properties of nocodazole, paclitaxel and griseofulvin in vitro. Centrosome defects and alterations in protein expression profiles

Journal of Applied Toxicology

Volumn 33, Issue 9, 2013, Pages 869-879

  Zacharaki, Polyxeni ^a   Stephanou, Georgia ^a   Demopoulos, Nikos A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Centrosome defects; Chromosome delay; Chromosome segregation regulating proteins; Griseofulvin; Metaphase arrest; Nocodazole; Paclitaxel

Indexed keywords

AURORA A KINASE; GAMMA TUBULIN; GRISEOFULVIN; NOCODAZOLE; PACLITAXEL;

ANEUGENIC ACTIVITY; ANEUPLOIDY; ARTICLE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL VIABILITY; CENTROSOME; CHROMOSOME; CHROMOSOME SEGREGATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; METAPHASE; MICRONUCLEUS; MICROTUBULE; MITOSIS INDEX; MYOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CENTROSOME DEFECTS; CHROMOSOME DELAY; CHROMOSOME SEGREGATION REGULATING PROTEINS; GRISEOFULVIN; METAPHASE ARREST; NOCODAZOLE; PACLITAXEL;

ANEUGENS; ANEUPLOIDY; ANIMALS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CENTROSOME; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GRISEOFULVIN; HUMANS; INTERPHASE; MCF-7 CELLS; METAPHASE; MICE; MICROTUBULES; MYOBLASTS; NOCODAZOLE; PACLITAXEL; TRANSCRIPTOME; TUBULIN;

EID: 84880704047     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2745     Document Type: Article

References (64)

1. Aardema MJ, Curry PT, Gudi R, Putman DL. 1996. Griseofulvin-induced structural and numerical chromosome aberrations in vitro and in vivo. Environ. Mol. Mutagen. 27: s27.
2. Alakhras RS, Stephanou G, Demopoulos NA, Nikolaropoulos SS. 2011. Genotoxicity of all-trans retinoic acid (ATRA) and its steroidal analogue EA-4 in human lymphocytes and mouse cells in vitro. Cancer Lett. 306: 15-26.
3. Anand S, Penrhyn-Lowe S, Venkitaraman AR. 2003. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3: 51-62.
4. Ben-Ze'ev A, Farmer SR, Penman S. 1979. Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell 17: 319-325.
5. Blajeski AL, Phan VA, Kottke TJ, Kaufmann SH. 2002. G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J. Clin. Invest. 110: 91-99.
6. Brinkley BR. 2001. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol. 11: 18-21.
7. Brinkley BR, Goepfert TM. 1998. Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. Cell Motil. Cytoskeleton 41: 281-288.
8. Chang YC, Nalbant P, Birkenfeld J, Chang ZF, Bokoch GM. 2008. GEF-H1 couples nocodazole-induced microtubule disassembly to cell contractility via RhoA. Mol. Biol. Cell 19: 2147-2153.
9. Chen JG, Horwitz SB. 2002. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res. 62: 1935-1938.
10. Cleveland DW, Mao Y, Sullivan KF. 2003. Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell 112: 407-421.
11. De Carli L, Larizza L. 1988. Griseofulvin. Mutat. Res. 195: 91-126.
12. De Clerck F, De Brabander M. 1977. Nocodazole, a new synthetic antimitotic agent, enhances the production of plasminogen activator by cells in culture. Thromb. Res. 11: 913-914.
13. Decordier I, Dillen L, Cundari E, Kirsch-Volders M. 2002. Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagenesis 17: 337-344.
14. Decordier I, Cundari E, Kirsch-Volders M. 2005. Influence of caspase activity on micronuclei detection: a possible role for caspase-3 in micronucleation. Mutagenesis 20: 173-179.
15. Decordier I, Cundari E, Kirsch-Volders M. 2008. Survival of aneuploid, micronucleated and/or polyploid cells: crosstalk between ploidy control and apoptosis. Mutat. Res. 651: 30-39.
16. Duesberg P, Rasnick D. 2000. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil. Cytoskeleton 47: 81-107.
17. Dutertre S, Descamps S, Prigent C. 2002. On the role of aurora-A in centrosome function. Oncogene 21: 6175-6183.
18. Efthimiou M, Andrianopoulos C, Stephanou G, Demopoulos NA, Nikolaropoulos SS. 2007. Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N, N-bis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro. Mutat. Res. 617: 125-137.
19. Efthimiou M, Ouranou D, Stephanou G, Demopoulos NA, Nikolaropoulos SS, Alevizos P. 2010. Comparative study of genetic activity of chlorambucil's active metabolite steroidal esters: the role of steroidal skeleton on aneugenic potential. Mutat. Res. 689: 1-11.
20. Elhajouji A, Cunha M, Kirsch-Volders M. 1998. Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononucleates in the cytokinesis-block assay. Mutagenesis 13: 193-198.
21. FDA. n.d. Official FDA Information on Drug Interactions. Available from: http://www.drugs.com/pro/griseofulvin
22. Fukasawa K. 2005. Centrosome amplification, chromosome instability and cancer development. Cancer Lett. 230: 6-19.
23. Georgiou CD, Grintzalis K, Zervoudakis G, Papapostolou I. 2008. Mechanism of Coomassie brilliant blue G-250 binding to proteins: a hydrophobic assay for nanogram quantities of proteins. Anal. Bioanal. Chem. 391: 391-403.
24. Glover DM, Leibowitz MH, McLean DA, Parry H. 1995. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell 81: 95-105.
25. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. 2000. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289: 2363-2366.
26. Hamilton BT, Snyder JA. 1982. Rapid completion of mitosis and cytokinesis in PtK cells following release from nocodazole arrest. Eur. J. Cell Biol. 28: 190-194.
27. Hashimoto K, Nakajima Y, Matsumura S, Chatani F. 2010. An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens. Toxicol. In Vitro 24: 208-216.
28. Heidemann S. 2006. Microtubules, leukemia, cough syrup. Blood 107: 2217-2218.
29. Ho YS, Duh JS, Jeng JH, Wang YJ, Liang YC, Lin CH, Tseng CJ, Yu CF, Chen RJ, Lin JK. 2001. Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int. J. Cancer 91: 393-401.
30. Iarmarcovai G, Botta A, Orsiere T. 2006. Number of centromeric signals in micronuclei and mechanisms of aneuploidy. Toxicol. Lett. 166: 1-10.
31. Jordan M, Hatjis CG, Habib N, Sivard J. 1992. Conservative management of splenic subcapsular hematoma in the third trimester of pregnancy. A case report. J. Reprod. Med. 37: 557-560.
32. Jordan MA, Toso RJ, Thrower D, Wilson L. 1993. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl Acad. Sci. USA 90: 9552-9556.
33. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. 1996. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56: 816-825.
34. Jordan A, Hadfield JA, Lawrence NJ, McGown AT. 1998. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev. 18: 259-296.
35. Kirkland D. 2010. Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): introduction to the collaborative trial. Mutat. Res. 702: 139-147.
36. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Lorge E, Norppa H, Surralles J, von der Hude W, Wakata A. 2000. Report from the In Vitro Micronucleus Assay Working Group. Environ. Mol. Mutagen. 35: 167-172.
37. Kirsch-Volders M, Plas G, Elhajouji A, Lukamowitcz M, Gonzalez L, Loock KM, Decordier I. 2011. The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch. Toxicol. 85: 873-899.
38. Knasmuller S, Parzefall W, Helma C, Kassie F, Ecker S, Schulte-Hermann R. 1997. Toxic effects of griseofulvin: disease models, mechanisms, risk assessment. Crit. Rev. Toxicol. 27: 495-537.
39. Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, Galvin KM, Hoar KM, Huck JJ, LeRoy PJ, Ray ET, Sells TB, Stringer B, Stroud SG, Vos TJ, Weatherhead GS, Wysong DR, Zhang M, Bolen JB, Claiborne CF. 2007. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc. Natl Acad. Sci. USA 104: 4106-4111.
40. Marx KA, Zhou T, Montrone A, McIntosh D, Braunhut SJ. 2007. A comparative study of the cytoskeleton binding drugs nocodazole and taxol with a mammalian cell quartz crystal microbalance biosensor: different dynamic responses and energy dissipation effects. Anal. Biochem. 361: 77-92.
41. Michalakis J, Georgatos SD, Romanos J, Koutala H, Georgoulias V, Tsiftsis D, Theodoropoulos PA. 2005. Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells. Cancer Chemother. Pharmacol. 56: 615-622.
42. Migliore L, Zotti-Martelli L, Scarpato R. 1999. Detection of chromosome loss and gain induced by griseofulvin, estramustine, vanadate in binucleated lymphocytes using FISH analysis. Environ. Mol. Mutagen. 34: 64-68.
43. Milas L, Hunter NR, Kurdoglu B, Mason KA, Meyn RE, Stephens LC, Peters LJ. 1995. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35: 297-303.
44. Murphy SM, Urbani L, Stearns T. 1998. The mammalian gamma-tubulin complex contains homologues of the yeast spindle pole body components spc97p and spc98p. J. Cell Biol. 141: 663-674.
45. Ochi T. 2002. Methylmercury, but not inorganic mercury, causes abnormality of centrosome integrity (multiple foci of gamma-tubulin), multipolar spindles and multinucleated cells without microtubule disruption in cultured Chinese hamster V79 cells. Toxicology 175: 111-121.
46. Panda D, Rathinasamy K, Santra MK, Wilson L. 2005. Kinetic suppression of microtubule dynamic instability by griseofulvin: implications for its possible use in the treatment of cancer. Proc. Natl Acad. Sci. USA 102: 9878-9883.
47. Pisano C, Battistoni A, Antoccia A, Degrassi F, Tanzarella C. 2000. Changes in microtubule organization after exposure to a benzimidazole derivative in Chinese hamster cells. Mutagenesis 15: 507-515.
48. Rathinasamy K, Jindal B, Asthana J, Singh P, Balaji PV, Panda D. 2010. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine. BMC Cancer 10: 213.
49. Rebacz B, Larsen TO, Clausen MH, Ronnest MH, Loffler H, Ho AD, Kramer A. 2007. Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen. Cancer Res. 67: 6342-6350.
50. Rieder CL, Schultz A, Cole R, Sluder G. 1994. Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J. Cell Biol. 127: 1301-1310.
51. Rowinsky EK, Donehower RC. 1995. Paclitaxel (taxol). New Engl. J. Med. 332: 1004-1014.
52. Rusan NM, Fagerstrom CJ, Yvon AM, Wadsworth P. 2001. Cell cycle-dependent changes in microtubule dynamics in living cells expressing green fluorescent protein-alpha tubulin. Mol. Biol. Cell 12: 971-980.
53. Schiff PB, Horwitz SB. 1980. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl Acad. Sci. USA 77: 1561-1565.
54. Shannon KB, Canman JC, Ben Moree C, Tirnauer JS, Salmon ED. 2005. Taxol-stabilized microtubules can position the cytokinetic furrow in mammalian cells. Mol. Biol. Cell 16: 4423-4436.
55. Shu HB, Joshi HC. 1995. Gamma-tubulin can both nucleate microtubule assembly and self-assemble into novel tubular structures in mammalian cells. J. Cell Biol. 130: 1137-1147.
56. Snedecor G, Cochran W. 1972. Statistical Methods. Iowa State University Press: Ames, IA.
57. Thompson WR, Nadal-Ginard B, Mahdavi V. 1991. A MyoD1-independent muscle-specific enhancer controls the expression of the beta-myosin heavy chain gene in skeletal and cardiac muscle cells. J. Biol. Chem. 266: 22678-22688.
58. Trippi F, Botto N, Scarpato R, Petrozzi L, Bonuccelli U, Latorraca S, Sorbi S, Migliore L. 2001. Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients. Mutagenesis 16: 323-327.
59. Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, Prigent C, Ambesi-Impiombato FS, D'Armiento M, Arlot-Bonnemains Y. 2006. Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. Int. J. Cancer 119: 275-282.
60. Weaver BA, Cleveland DW. 2005. Decoding the links between mitosis, cancer, chemotherapy: The mitotic checkpoint, adaptation, cell death. Cancer Cell 8: 7-12.
61. Yaffe D, Saxel O. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
62. Yuen KW, Montpetit B, Hieter P. 2005. The kinetochore and cancer: what's the connection? Curr. Opin. Cell Biol. 17: 576-582.
63. Yvon AM, Wadsworth P, Jordan MA. 1999. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell 10: 947-959.
64. Zhou J, Giannakakou P. 2005. Targeting microtubules for cancer chemotherapy. Curr. Med. Chem. Anticancer Agents 5: 65-71.